Biomea Fusion, Inc. (BMEA) stock
BMEANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.56−0.05 (-7.89%)
Close on Nov 12, 2026Market cap $40.79MP/E –Yield –
Earnings
Biomea Fusion's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue, Q3 FY2025
–
EPS, Q3 FY2025
-$0.27
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Biomea Fusion's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q1 FY2026ended Mar 31, 2026 | May 11, 2026after the close | – | – | – | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 24, 2026after the close | – | – | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 4, 2025after the close | – | – | -$0.27 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 5, 2025after the close | – | – | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 5, 2025after the close | – | – | -$0.80 | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 31, 2025after the close | – | – | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 29, 2024after the close | – | – | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 31, 2024after the close | – | – | – | Release |
| Q1 FY2024ended Mar 31, 2024 | May 2, 2024after the close | – | – | -$1.09 | Release |
| Q4 FY2023ended Dec 31, 2023 | Apr 1, 2024after the close | – | – | -$0.98 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 30, 2023after the close | – | – | -$0.80 | Release |
| Q2 FY2023ended Jun 30, 2023 | Jul 31, 2023after the close | – | – | -$0.70 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 2, 2023after the close | – | – | -$0.98 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 28, 2023after the close | – | – | -$0.86 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 7, 2022after the close | – | – | -$0.78 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 1, 2022after the close | – | – | -$0.59 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 16, 2022before the open | – | – | -$0.56 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 28, 2022after the close | – | – | -$0.51 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 3, 2021after the close | – | – | -$0.43 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 11, 2021after the close | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 27, 2021after the close | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Biomea Fusion has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Biomea Fusion puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Biomea Fusion filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- Results
- Update
- Results
- Update
- Update
- Update
- Results
- News
- News
- Results
- News
- News
- Update
See a number that looks wrong?